Search

Search Constraints

You searched for: Author/Creator Assal, Frederic

Search Results

1. O4‐04‐03: THE BIOLOGICAL BASIS OF COGNITIVE IMPAIRMENT DUE TO SUSPECTED NON‐ALZHEIMER'S PATHOLOGY (SNAP): STUDY DESIGN AND BASELINE COHORT FEATURES. (1st July 2019)

2. P1‐393: THE INCREMENTAL VALUE OF AMYLOID PET VERSUS CSF BIOMARKERS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE (INDIA–FBB STUDY). (1st July 2006)

3. P4‐093: VISUAL RATING SCALES IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT CHARACTERIZED FOR AMYLOIDOSIS. (1st July 2006)

4. P3‐209: Impact of Biomarkers On Diagnostic Confidence in Clinical Assessment of Patients with Suspected Alzheimer's Disease and High Diagnostic Uncertainty: An EADC Study. (1st July 2016)

5. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study. Issue 9 (3rd March 2017)

6. IC‐P‐007: VISUAL RATING SCALES IN SUBJECTS WITH MILD COGNITIVE IMPAIRMENT CHARACTERIZED FOR AMYLOIDOSIS. (1st July 2006)

7. IC‐P‐006: THE INCREMENTAL VALUE OF AMYLOID PET VERSUS CSF BIOMARKERS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE (INDIA–FBB STUDY). (1st July 2006)

8. P2‐370: AMYLOID‐PET FOR MYELIN IMAGING IN ALZHEIMER'S DISEASE. (1st July 2006)

9. One‐year persistent symptoms and functional impairment in SARS‐CoV‐2 positive and negative individuals. (31st March 2022)

10. Anticholinergic and Sedative Medications Are Associated With Neurocognitive Performance of Well Treated People With Human Immunodeficiency Virus. (2nd September 2022)